Speakers

Prof. Kostas Kostarelos, The University of Manchester

Kostas is Professor and Chair of Nanomedicine at the Faculty of Medical and Human Sciences of the University of Manchester. He is leading the Nanomedicine Lab that is part of the Centre for Tissue Injury and Repair and the National Graphene Institute.


Dr Lubomir Gradinarsky, AstraZeneca

Lubomir Gradinarsky an Associate Principle Scientist in Novel Packaging at AstraZeneca R&D Gothenburg, Sweden, since 2003.

He is also Adjunct Associate Professor in Industrial Measurement Techniques at Chalmers University of Technology, Gothenburg, Sweden.


Dr Daniel Chew, Glaxo Smith Kline

Daniel Chew is Neural Interface Manager in Bioelectronics. Having PhD studies in
neuroscience at Queen Mary University of London, he moved to the University of Cambridge to undertake research into novel peripheral nerve interfaces for closed-loop control of organ function and disease treatment. He has extensive experience of small animal surgery and device implantation, electrophysiology, neurophysiology, and device engineering. He currently heads the neural interfacing technology portfolio of Bioelectronics, with responsibilities in sourcing, creating and driving academic and industry collaborative projects. In tandem, he is responsible for holding and maintaining the Home Office Project License for internal resourcing of pre-clinical modelling of Bioelectronic Medicines within the Laboratory Animal Sciences of GSK.


Guillaume Buc, Pixium Vision

Guillaume Buc is Pixium Vision’s Chief Technology Officer since July 2013. He has over 15 years of experience in senior technology development and management roles at GE Healthcare (“GEHC”) and 20 years of overall experience in medical device development and program management. Mr Buc holds Engineering degrees in Image Processing, Applied Mathematics and Computer Science from Ecole Polytechnique and Ecole Nationale Supérieure des Télécommunications de Paris.

Prof. François Berger, Clinatec

François Berger is Clinatec director since 2011 and leads CLINATEC TRANSLATIONAL TECHNOLOGY LAB. François Berger, MD,PhD had a dual scientific and clinical education in the field of neurology, oncology and molecular and cell biology. He continues to have a dual clinical and research activity has professor of cell biology and neuro-oncology. He develops a translational research activity, trying to validate innovative technologies at the preclinical/clinical level in close collaboration with CEA-LETI micro-nanotechnology centre. His role in the project will be to design innovative preclinical application of graphene in vivo, for deep brain application and to translate these preclinical finding in pilot clinical trials able to be submitted at the end of the project.

Dr Clemens Boucsein, Multichannel Systems

Clemens Boucsein heads the hardware development at Multichannel Systems.






Page Contact:
Publishing date: 29 September 2016 20:47